US8999957, Table 2, Compound 54

ID: ALA3654529

Chembl Id: CHEMBL3654529

PubChem CID: 89509115

Max Phase: Preclinical

Molecular Formula: C29H30FN5O4

Molecular Weight: 531.59

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)C1CC(NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN(Cc2c(F)cccc2OC)C1

Standard InChI:  InChI=1S/C29H30FN5O4/c1-17-11-18(9-10-31-17)27-22-13-19(7-8-25(22)33-34-27)28(36)32-21-12-20(29(37)39-3)14-35(15-21)16-23-24(30)5-4-6-26(23)38-2/h4-11,13,20-21H,12,14-16H2,1-3H3,(H,32,36)(H,33,34)

Standard InChI Key:  PWVKOSZQCHQTHA-UHFFFAOYSA-N

Associated Targets(non-human)

Mapk3 Mitogen-activated protein kinase 3 (111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 531.59Molecular Weight (Monoisotopic): 531.2282AlogP: 3.87#Rotatable Bonds: 7
Polar Surface Area: 109.44Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.21CX Basic pKa: 6.31CX LogP: 3.04CX LogD: 3.00
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -1.34

References

1.  (2015)  Heterocyclic compounds as ERK inhibitors, 

Source

Source(1):